Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Quality Index
Meditera Tibbi Malzeme Sanayi ve Ticaret AS cash flow quality index. Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow Quality Index of 2.15x as of December 2025. Operating cash flow of TL140.82 Million exceeds net income of TL65.61 Million, indicating high earnings quality where cash backs reported profits. See MEDTR financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2024)
Cash flow quality index of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2024. Historical Cash Flow Quality Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Meditera Tibbi Malzeme Sanayi ve Ticaret to assess how comfortably operating cash covers total debt obligations.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Quality Index by Year (2018–2024)
Meditera Tibbi Malzeme Sanayi ve Ticaret AS cash flow quality index by year from 2018 to 2024. Year-by-year earnings quality comparison for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For the full cash flow conversion analysis, see Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) cash conversion ratio.
| Year | Quality Index | Operating CF (TRY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 8.12x | TL780.69 Million | TL96.11 Million | ▼ -62.1% |
| 2023 | 21.45x | TL801.02 Million | TL37.35 Million | ▲ +124822.4% |
| 2022 | 0.02x | TL5.10 Million | TL297.05 Million | ▼ -92.1% |
| 2021 | 0.22x | TL36.64 Million | TL167.70 Million | ▼ -82.0% |
| 2020 | 1.21x | TL73.26 Million | TL60.43 Million | ▼ -22.8% |
| 2019 | 1.57x | TL20.01 Million | TL12.73 Million | ▼ -73.2% |
| 2018 | 5.87x | TL73.26 Million | TL12.49 Million | — |